SSCI, part of AMRI’s Global Analytical Services, has increased capacity  by implementing Malvern’s next-generation laser diffraction instrument Mastersizer 3000. This move was in response to industry demand for the company’s cGMP particle characterization services.

“The ubiquity of Malvern Mastersizer instruments throughout the pharmaceutical industry, consistency of data across instruments, and Malvern Instruments’ continuing commitment to comply with data integrity requirements has led to SSCI’s choice of the Mastersizer 3000 to further expand its cGMP capabilities for particle size analysis,” Patricia Andres, Ph.D., director particle engineering at SSCI. 

Malvern Panalytical’s technologies confirm the identity, activity, molecular conformation, morphological properties, solid form and stability of APIs and excipients. To date, SSCI has developed more than 300 methods for the particle size analysis of APIs and drug products using its current stable of Malvern Mastersizers.